Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey139d agoneutral
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee AcquisitionBloomberg139d agoneutralVIDEO
AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock MoversInvestor's Business Daily139d agoneutral
AbbVie Goes On The Offensive With $10.9 Billion TakeoverInvesting.com139d agoneutral
Apogee Therapeutics, BitFuFu rise premarket; AbbVie gains after dealBloomberg142d agoneutral
Stocks Slide as Focus Shifts to Iran Deal Hurdles: Markets Wrap24/7 Wall St.158d agoneutral
This Is What a $1 Million Dividend Portfolio Pays After TaxesGuruFocus.com160d agoneutral
Glenmark Pharmaceuticals Ltd (BOM:532296) Q4 2026 Earnings Call Highlights: Strong Revenue ...The Wall Street Journal164d agoneutral
J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?The Wall Street Journal164d agoneutral
J&J Mastered Cancer Biotech Deals on the Cheap. Can It Stay on the Cutting Edge?Simply Wall St.177d agoneutral
AbbVie's (NYSE:ABBV) Soft Earnings Are Actually Better Than They AppearBarchart185d agoneutral
AbbVie Delivers Strong Q1 Earnings Beyond Humira. This Dividend King Still Shines.Investor's Business Daily186d agoneutral
This Small Biotech - Taking On AbbVie, Novartis And Sanofi - Just Catapulted Into A Breakout